Comparison of two preoperative chemoradiotherapy regimens for locally advanced rectal cancer: capecitabine alone versus capecitabine plus irinotecan
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1748-717X
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Comparison of two preoperative chemoradiotherapy regimens for locally advanced rectal cancer: capecitabine alone versus capecitabine plus irinotecan ; volume:8 ; number:1 ; day:4 ; month:11 ; year:2013 ; pages:1-7 ; date:12.2013
Radiation oncology ; 8, Heft 1 (4.11.2013), 1-7, 12.2013
- Urheber
-
Lee, Sung Uk
- Beteiligte Personen und Organisationen
-
Kim, Dae Yong
Kim, Sun Young
Baek, Ji Yeon
Chang, Hee Jin
Kim, Min Ju
Kim, Tae Hyun
Park, Ji Won
Oh, Jae Hwan
SpringerLink (Online service)
- DOI
-
10.1186/1748-717X-8-258
- URN
-
urn:nbn:de:1111-201604095846
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:55 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lee, Sung Uk
- Kim, Dae Yong
- Kim, Sun Young
- Baek, Ji Yeon
- Chang, Hee Jin
- Kim, Min Ju
- Kim, Tae Hyun
- Park, Ji Won
- Oh, Jae Hwan
- SpringerLink (Online service)
Ähnliche Objekte (12)
Preoperative chemoradiotherapy with capecitabine and triweekly oxaliplatin versus capecitabine monotherapy for locally advanced rectal cancer: a propensity-score matched study
Capecitabine-Associated Terminal Ileitis
Phase II study of weekly irinotecan and capecitabine treatment in metastatic colorectal cancer patients
Comparison of capecitabine and 5-fluorouracil in chemoradiotherapy for locally advanced pancreatic cancer
Photosensitive lichenoid skin reaction to capecitabine
Capecitabine and irinotecan with bevacizumab 2-weekly for metastatic colorectal cancer: the phase II AVAXIRI study
Fisetin and/or capecitabine causes changes in apoptosis pathways in capecitabine-resistant colorectal cancer cell lines
Prospective clinical study of capecitabine plus oxaliplatin concurrent chemoradiotherapy after radical resection of rectal cancer
Management of patients with reduced dihydropyrimidine dehydrogenase activity receiving combined 5-fluoruracil-/capecitabine-based chemoradiotherapy
Temozolomide Alone or Combined with Capecitabine for the Treatment of Advanced Pancreatic Neuroendocrine Tumor
Adherence Management for Cancer Patients on Capecitabine
Identification and cost of adverse events in metastatic breast cancer in taxane and capecitabine based regimens
Preoperative chemoradiotherapy with capecitabine and triweekly oxaliplatin versus capecitabine monotherapy for locally advanced rectal cancer: a propensity-score matched study
Capecitabine-Associated Terminal Ileitis
Phase II study of weekly irinotecan and capecitabine treatment in metastatic colorectal cancer patients
Comparison of capecitabine and 5-fluorouracil in chemoradiotherapy for locally advanced pancreatic cancer
Photosensitive lichenoid skin reaction to capecitabine
Capecitabine and irinotecan with bevacizumab 2-weekly for metastatic colorectal cancer: the phase II AVAXIRI study
Fisetin and/or capecitabine causes changes in apoptosis pathways in capecitabine-resistant colorectal cancer cell lines
Prospective clinical study of capecitabine plus oxaliplatin concurrent chemoradiotherapy after radical resection of rectal cancer
Management of patients with reduced dihydropyrimidine dehydrogenase activity receiving combined 5-fluoruracil-/capecitabine-based chemoradiotherapy
Temozolomide Alone or Combined with Capecitabine for the Treatment of Advanced Pancreatic Neuroendocrine Tumor
Adherence Management for Cancer Patients on Capecitabine
Identification and cost of adverse events in metastatic breast cancer in taxane and capecitabine based regimens
Preoperative chemoradiotherapy with capecitabine and triweekly oxaliplatin versus capecitabine monotherapy for locally advanced rectal cancer: a propensity-score matched study
Capecitabine-Associated Terminal Ileitis
Phase II study of weekly irinotecan and capecitabine treatment in metastatic colorectal cancer patients
Comparison of capecitabine and 5-fluorouracil in chemoradiotherapy for locally advanced pancreatic cancer
Photosensitive lichenoid skin reaction to capecitabine
Capecitabine and irinotecan with bevacizumab 2-weekly for metastatic colorectal cancer: the phase II AVAXIRI study
Fisetin and/or capecitabine causes changes in apoptosis pathways in capecitabine-resistant colorectal cancer cell lines
Prospective clinical study of capecitabine plus oxaliplatin concurrent chemoradiotherapy after radical resection of rectal cancer
Management of patients with reduced dihydropyrimidine dehydrogenase activity receiving combined 5-fluoruracil-/capecitabine-based chemoradiotherapy
Temozolomide Alone or Combined with Capecitabine for the Treatment of Advanced Pancreatic Neuroendocrine Tumor
Adherence Management for Cancer Patients on Capecitabine